Medifast Inc
NYSE:MED
Balance Sheet
Balance Sheet Decomposition
Medifast Inc
Medifast Inc
Balance Sheet
Medifast Inc
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
3
|
1
|
2
|
1
|
2
|
2
|
0
|
0
|
14
|
40
|
36
|
25
|
42
|
52
|
75
|
81
|
77
|
164
|
104
|
88
|
94
|
91
|
89
|
|
| Cash Equivalents |
1
|
3
|
1
|
2
|
1
|
2
|
2
|
0
|
0
|
14
|
40
|
36
|
25
|
42
|
52
|
75
|
81
|
77
|
164
|
104
|
88
|
94
|
91
|
89
|
|
| Short-Term Investments |
0
|
4
|
3
|
3
|
2
|
1
|
1
|
16
|
34
|
20
|
20
|
31
|
28
|
25
|
24
|
24
|
20
|
16
|
11
|
5
|
0
|
56
|
71
|
78
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
4
|
7
|
3
|
1
|
7
|
3
|
3
|
3
|
1
|
7
|
1
|
1
|
0
|
9
|
0
|
0
|
|
| Accounts Receivables |
0
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
2
|
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
5
|
1
|
0
|
5
|
2
|
1
|
2
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
3
|
4
|
6
|
8
|
9
|
14
|
11
|
20
|
20
|
21
|
18
|
16
|
13
|
18
|
19
|
39
|
49
|
53
|
180
|
119
|
55
|
42
|
20
|
|
| Other Current Assets |
1
|
2
|
1
|
4
|
3
|
4
|
3
|
5
|
3
|
3
|
5
|
6
|
7
|
3
|
4
|
4
|
5
|
6
|
6
|
16
|
16
|
11
|
10
|
14
|
|
| Total Current Assets |
4
|
12
|
10
|
14
|
15
|
17
|
22
|
36
|
61
|
64
|
89
|
92
|
82
|
87
|
101
|
125
|
146
|
154
|
234
|
307
|
223
|
224
|
214
|
202
|
|
| PP&E Net |
5
|
7
|
9
|
10
|
14
|
17
|
22
|
23
|
31
|
39
|
40
|
35
|
34
|
29
|
20
|
19
|
20
|
39
|
38
|
81
|
76
|
67
|
49
|
38
|
|
| PP&E Gross |
5
|
7
|
9
|
10
|
14
|
17
|
22
|
23
|
31
|
39
|
0
|
35
|
34
|
29
|
20
|
19
|
20
|
39
|
38
|
81
|
76
|
67
|
49
|
38
|
|
| Accumulated Depreciation |
2
|
2
|
3
|
4
|
5
|
7
|
9
|
13
|
18
|
25
|
0
|
32
|
40
|
47
|
36
|
34
|
35
|
23
|
27
|
33
|
40
|
47
|
58
|
68
|
|
| Intangible Assets |
1
|
4
|
6
|
5
|
6
|
7
|
6
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
2
|
2
|
1
|
6
|
1
|
0
|
0
|
2
|
4
|
2
|
4
|
11
|
18
|
19
|
21
|
8
|
|
| Other Assets |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
10
N/A
|
24
+144%
|
26
+7%
|
30
+16%
|
37
+22%
|
44
+19%
|
50
+15%
|
63
+25%
|
94
+49%
|
106
+12%
|
130
+23%
|
133
+2%
|
116
-13%
|
116
+0%
|
121
+4%
|
146
+20%
|
169
+16%
|
195
+15%
|
276
+42%
|
398
+44%
|
316
-21%
|
310
-2%
|
284
-8%
|
248
-13%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
1
|
0
|
2
|
2
|
3
|
4
|
4
|
9
|
13
|
28
|
12
|
12
|
11
|
10
|
16
|
22
|
23
|
36
|
71
|
59
|
48
|
23
|
15
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
6
|
6
|
0
|
10
|
10
|
8
|
11
|
15
|
29
|
39
|
54
|
74
|
55
|
42
|
39
|
27
|
|
| Short-Term Debt |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
4
|
4
|
6
|
9
|
18
|
21
|
25
|
27
|
2
|
2
|
1
|
|
| Total Current Liabilities |
2
|
3
|
3
|
4
|
5
|
7
|
9
|
9
|
16
|
20
|
29
|
27
|
27
|
24
|
24
|
37
|
60
|
79
|
111
|
170
|
141
|
92
|
64
|
43
|
|
| Long-Term Debt |
3
|
5
|
4
|
4
|
4
|
5
|
4
|
5
|
5
|
4
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
8
|
7
|
7
|
6
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
10
|
8
|
26
|
20
|
16
|
10
|
6
|
|
| Total Liabilities |
4
N/A
|
7
+67%
|
7
-6%
|
8
+24%
|
9
+5%
|
11
+28%
|
15
+34%
|
15
N/A
|
22
+46%
|
32
+46%
|
40
+22%
|
34
-13%
|
35
+4%
|
28
-22%
|
25
-8%
|
37
+48%
|
60
+62%
|
90
+49%
|
119
+32%
|
196
+65%
|
161
-18%
|
108
-33%
|
74
-32%
|
49
-34%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
5
|
3
|
1
|
1
|
6
|
10
|
12
|
23
|
42
|
61
|
77
|
98
|
79
|
89
|
94
|
104
|
131
|
169
|
154
|
190
|
140
|
175
|
177
|
158
|
|
| Additional Paid In Capital |
10
|
20
|
21
|
22
|
27
|
27
|
25
|
29
|
33
|
36
|
40
|
0
|
1
|
0
|
3
|
5
|
9
|
0
|
8
|
12
|
22
|
27
|
33
|
40
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
24
|
27
|
0
|
0
|
0
|
0
|
0
|
31
|
64
|
5
|
0
|
6
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
17
+205%
|
19
+12%
|
22
+13%
|
28
+29%
|
32
+16%
|
35
+9%
|
48
+36%
|
72
+51%
|
73
+2%
|
91
+24%
|
98
+8%
|
81
-18%
|
89
+10%
|
96
+8%
|
109
+13%
|
109
+0%
|
105
-4%
|
157
+50%
|
203
+29%
|
155
-23%
|
201
+30%
|
210
+4%
|
199
-5%
|
|
| Total Liabilities & Equity |
10
N/A
|
24
+144%
|
26
+7%
|
30
+16%
|
37
+22%
|
44
+19%
|
50
+15%
|
63
+25%
|
94
+49%
|
106
+12%
|
130
+23%
|
133
+2%
|
116
-13%
|
116
+0%
|
121
+4%
|
146
+20%
|
169
+16%
|
195
+15%
|
276
+42%
|
398
+44%
|
316
-21%
|
310
-2%
|
284
-8%
|
248
-13%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
7
|
10
|
11
|
13
|
14
|
14
|
14
|
15
|
15
|
16
|
14
|
13
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
11
|
11
|
11
|
11
|
|
| Preferred Shares Outstanding |
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|